Hematopoiesis: How Blood Cells Are Made in the Bone Marrow

Hematopoiesis is the continuous, tightly regulated process of blood cell formation from hematopoietic stem cells (HSCs) in the bone marrow.

Sites of Hematopoiesis

  • Fetal: Yolk sac → liver/spleen → bone marrow (by 28 weeks).
  • Adult: Axial skeleton (vertebrae, ribs, sternum, pelvis, skull) and long bone epiphyses (femur, humerus).
  • Extramedullary: Reactivated in severe anemia, myelofibrosis, or marrow infiltration (liver/spleen).

Hierarchy of Differentiation

  1. HSC (Long-term & Short-term): Self-renewal + multipotency. Markers: CD34⁺, CD38⁻, CD90⁺, CD45RA⁻.
  2. MPP (Multipotent Progenitors): Limited self-renewal; lymphoid + myeloid potential.
  3. Lineage-Committed Progenitors:
    • CLP (Common Lymphoid Progenitor): → T cells, B cells, NK cells, ILCs.
    • CMP (Common Myeloid Progenitor): → GMP + MEP.
    • GMP (Granulocyte-Monocyte Progenitor): → Neutrophils, eosinophils, basophils, monocytes/macrophages, dendritic cells.
    • MEP (Megakaryocyte-Erythroid Progenitor): → Erythrocytes, Megakaryocytes → Platelets.

Regulation

  • Cytokines/Growth Factors:
    • Erythropoietin (EPO, kidney) → erythropoiesis
    • Thrombopoietin (TPO, liver) → megakaryopoiesis
    • G-CSF → neutrophilia
    • GM-CSF, IL-3, SCF (stem cell factor) → multi-lineage
    • IL-7 → lymphopoiesis
  • Niche signals: Osteoblasts, endothelial cells, mesenchymal stromal cells, sympathetic nerves (CXCL12, SCF, Ang-1, Notch).
  • Transcription factors: PU.1, GATA1, C/EBPα, RUNX1, IKAROS—direct lineage fate decisions.

Cell Products & Functions

CellLifespanKey Function
Erythrocytes (RBCs)120 daysO₂/CO₂ transport (hemoglobin)
Neutrophils6–8 hrs (blood); days (tissue)Acute bacterial/fungal defense (phagocytosis, NETs)
Lymphocytes (T, B, NK)Days–years (memory)Adaptive immunity, immune surveillance
Monocytes/MacrophagesMonthsPhagocytosis, antigen presentation, tissue repair
Platelets7–10 daysHemostasis, thrombosis, wound healing

Clinical Disorders

  • Anemia: Low RBCs/hemoglobin (iron deficiency, B12/folate, hemolysis, marrow failure).
  • Leukemia: Malignant clonal expansion of hematopoietic precursors (AML, ALL, CML, CLL).
  • Myelodysplastic syndromes (MDS): Dysplastic ineffective hematopoiesis → cytopenias, AML risk.
  • Aplastic anemia: Marrow failure (immune-mediated, toxins, genetic).
  • Myeloproliferative neoplasms (MPN): Overproduction (PV, ET, MF).
  • Thrombocytopenia/Thrombocytosis: Platelet disorders.

Clinical Assessment

  • CBC with differential, reticulocyte count, peripheral smear.
  • Bone marrow aspirate/biopsy (cellularity, morphology, flow cytometry, cytogenetics, molecular).
  • EPO level, iron studies, B12/folate, genetic testing as indicated.

Blood Disorders - Related Articles